| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6041108 | Neuromuscular Disorders | 2016 | 16 Pages |
Abstract
Between November 2011 and April 2014, 398 patients with suspected FMS who had been assessed by a rheumatologist participated in this cross-sectional study. 95% of the study population was female, with a mean age of 42 years. The final ICD-9 diagnoses were collected, in 96% the diagnosis was FMS. 92% met the 2010 American College of Rheumatology (ACR) diagnostic criteria for FMS. A questionnaire including neuromuscular symptoms was completed. Creatine kinase was determined, and genetic testing for DM2 was conducted in all patients. DM2 was established in only one patient (0.25%, 95% CI 0.04-1.4%), thus disapproving our hypothesis of a relevant prevalence of 2%. Our results suggest that patients with suspected FMS should not routinely be tested for DM2.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
J. van Vliet, A. Verrips, A.A. Tieleman, H. Scheffer, H.A. Cats, A.A. den Broeder, B.G.M. van Engelen,